Previous 10 | Next 10 |
PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA ® (pembrolizumab) Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its PD-L1 IHC 22C3 pharmDx assay for expand...
Agilent Technologies Inc. (NYSE: A) announced today the results of its first Pharma Lab Leaders Survey looking to gather insights from pharmaceutical, biopharmaceutical, and contract research laboratories in seven countries around the world. Respondents included 650 laboratory managers...
An intuitive quadrupole that incorporates ‘designed-in’ smart features Agilent Technologies Inc. (NYSE: A) introduced the newest member of its LC/MS portfolio today at the American Society for Mass Spectrometry Conference ( ASMS ) which is being held June 2 through...
Powerful solutions for today’s mass spectrometry laboratory Agilent Technologies Inc. (NYSE: A) announced today cutting-edge lab technology solutions on show at the American Society for Mass Spectrometry Conference ( ASMS ) which is being held June 2 through June 6 in A...
ImmunoGen (NASDAQ: IMGN ) -31% . More news on: ImmunoGen, Inc., Sunworks, Inc., Co-Diagnostics, Inc., Stocks on the move Read more ...
The following slide deck was published by Agilent Technologies, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Agilent Technologies, Inc. (A) Q2 2019 Results Conference Call May 14, 2019 04:30 PM ET Company Participants Ankur Dhingra - Vice President of Investor Relations Mike McMullen - President and CEO Bob McMahon - Senior Vice President and CFO Jacob Thaysen - President of Life Scie...
Gainers: TCS +13.2% . TLRY +4.9% . HEXO +4.2% . ACB +2.8% . HCM +1.8% . More news on: The Container Store Group, Inc., Tilray, Inc., HEXO Corp., Stocks on the move, Read more ...
Agilent (NYSE: A ) fiscal Q2 results ($M): Revenue: 1,238 (+2.7%). More news on: Agilent Technologies, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Agilent (NYSE: A ): Q2 Non-GAAP EPS of $0.71 misses by $0.01 ; GAAP EPS of $0.57 misses by $0.06 . Revenue of $1.24B (+2.5% Y/Y) misses by $30M . Shares -6.7% . Press Release More news on: Agilent Technologies, Inc., Earnings news and commentary, Healthcare stocks news,
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
MAGE-A4 IHC 1F9 pharmDx is indicated as an aid in identifying patients with synovial sarcoma for whom TECELRA ® , a MAGE-A4-directed engineered T-Cell Receptor (TCR) therapy is being considered Agilent Technologies Inc. , (NYSE: A) today announced that it has received FDA a...
2024-08-01 15:15:03 ET William Blair analyst issues OUTPERFORM recommendation for A on August 1, 2024 01:31PM ET. The previous analyst recommendation was Outperform. A was trading at $143.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...